PLI Scheme for Pharmaceutical Manufacturing
- On 24th February, 2021, the Union Cabinet approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.
- The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry.
- It seeks to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector.
- It also aims to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains.
Need
- At present, low ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Economy Watch
- 1 Samarth Incubation Program
- 2 Centre Notifies Revised Criteria for Classifying MSMEs
- 3 PAC Flags Issues Faced by MSMEs under GST
- 4 Electronics Component Manufacturing Scheme
- 5 Energy Statistics India 2025
- 6 10 Years of Sagarmala Programme: Powering India’s Maritime Revolution
- 7 Changing Dynamics of India’s Remittances
- 8 Components of Gold Monetisation Scheme Discontinued
- 9 ICRA Report on Indian Municipal Bond Market
- 10 Pashu Aushadhi Initiative